These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30700688)

  • 1. [A case of meningoencephalitis associated with pembrolizumab treated for squamous cell lung cancer].
    Yonenobu Y; Ishijima M; Toyooka K; Fujimura H
    Rinsho Shinkeigaku; 2019 Feb; 59(2):105-108. PubMed ID: 30700688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab-induced pancytopenia in a patient with squamous cell lung cancer.
    Ueki Y; Suzuki M; Horikawa Y; Watanabe H; Yamaguchi Y; Morita C; Tsukada A; Takumida H; Kusaba Y; Katsuno T; Tsujimoto Y; Sakamoto K; Hashimoto M; Terada J; Ishii S; Takasaki J; Naka G; Iikura M; Izumi S; Takeda Y; Hojo M; Sugiyama H
    Thorac Cancer; 2020 Sep; 11(9):2731-2735. PubMed ID: 32767641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma.
    Yoshida M; Hara S; Nishioka R; Kobayashi T; Murase Y; Kimura H; Mizushima I; Kawano M
    Intern Med; 2024 Jul; 63(14):2089-2096. PubMed ID: 38072406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
    Beck TN; Kudinov AE; Dulaimi E; Boumber Y
    BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment of Guillain-Barré syndrome-like acute inflammatory demyelinating polyneuropathy caused by pembrolizumab with a combination of corticosteroid and immunoglobulins: a case report].
    Hashimoto R; Ueda T; Tsuji Y; Otsuka Y; Sekiguchi K; Matsumoto R
    Rinsho Shinkeigaku; 2020 Nov; 60(11):773-777. PubMed ID: 33115993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed immune-related neutropenia with hepatitis by pembrolizumab.
    Nakako S; Nakashima Y; Okamura H; Tani Y; Ueda T; Makuuchi Y; Kuno M; Takakuwa T; Nishimoto M; Koh H; Nakamae H; Hino M
    Immunotherapy; 2022 Feb; 14(2):101-105. PubMed ID: 34758635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab.
    Taki T; Oda N; Fujioka Y; Mitani R; Tokura T; Takata I; Oshiro Y; Takigawa N
    Intern Med; 2020 Jul; 59(13):1639-1642. PubMed ID: 32269191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review.
    Murakami S; Nagano T; Nakata K; Onishi A; Umezawa K; Katsurada N; Yamamoto M; Tachihara M; Kobayashi K; Nishimura Y
    Intern Med; 2019 Oct; 58(19):2839-2843. PubMed ID: 31243239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dramatic, significant metabolic response to a one-time pembrolizumab treatment following a relapse of pre-existing organizing pneumonia in a patient with advanced non-small cell lung cancer: A case report.
    Kato M; Mori M; Miura K; Asao T; Motomura H; Nishino K; Ko R; Koyama R; Hayashi T; Takahashi K
    Thorac Cancer; 2021 Nov; 12(22):3076-3079. PubMed ID: 34617405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pembrolizumab-induced agranulocytosis.
    Fernández Martínez V; García-Avello Fernández-Cueto A; Valencia Soto CM; Barbadillo Villanueva S; Ochagavía Sufrategui M; Rioja Carrera M; Alonso Buznego LA; Valero Domínguez M
    J Oncol Pharm Pract; 2024 Jun; 30(4):767-771. PubMed ID: 38291678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
    Kurokawa K; Hara M; Iwakami SI; Genda T; Iwakami N; Miyashita Y; Fujioka M; Sasaki S; Takahashi K
    Intern Med; 2019; 58(22):3283-3287. PubMed ID: 31735738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer.
    Okawa S; Kayatani H; Fujiwara K; Ozeki T; Takada K; Iwamoto Y; Minami D; Sato K; Shibayama T
    Intern Med; 2019; 58(5):699-702. PubMed ID: 30828042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of meningoencephalitis and polyradiculoneuropathy induced by combination therapy with ipilimumab and nivolumab].
    Ohno N; Sugimoto T; Giga M; Naito H; Kono T; Nomura E
    Rinsho Shinkeigaku; 2021 Oct; 61(10):658-662. PubMed ID: 34565749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma.
    Nardin C; Borot S; Beaudoin MA; Cattin F; Puzenat E; Gauthier AS; Schillo F; Borg C; Aubin F
    Invest New Drugs; 2019 Apr; 37(2):375-377. PubMed ID: 30145624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An elderly case of squamous cell lung cancer treated continuously with pembrolizumab without any decline in the life function].
    Sazuka M; Murano Y; Takada K; Nonaka K; Yamada H; Yamamoto H
    Nihon Ronen Igakkai Zasshi; 2018; 55(4):679-685. PubMed ID: 30542036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe inflammatory myopathy in a pulmonary carcinoma patient treated with Pembrolizumab: An alert for myologists.
    Peverelli L; De Rosa A; Domina E; Ciscato P; Sita G; Velardo D; Comi GP
    J Neuromuscul Dis; 2020; 7(4):511-514. PubMed ID: 32623405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
    Naqash AR; Appah E; Yang LV; Muzaffar M; Marie MA; Mccallen JD; Macherla S; Liles D; Walker PR
    J Immunother Cancer; 2019 Jul; 7(1):169. PubMed ID: 31277704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracheoesophageal Fistula Caused by Successful Response to Pembrolizumab in a Patient With Squamous Cell Lung Cancer.
    Wang H; Zhang L; Liu W
    J Thorac Oncol; 2019 Jul; 14(7):e141-e143. PubMed ID: 31235036
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal Effects after Pembrolizumab Treatment for Non-small Cell Lung Carcinoma.
    Oki R; Hirakawa Y; Kimura H; Honda K; Hinata M; Abe H; Domoto Y; Tanaka G; Nagase T; Nangaku M
    Intern Med; 2020 Apr; 59(7):977-981. PubMed ID: 31813918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.